![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/genprex-announces-the-appointment-of-jose-a-moreno-toscano-as-chairman-of-the-board-of-directors-302142996.html
https://www.prnewswire.com/news-releases/genprex-expands-clinical-trial-sites-for-acclaim-3-clinical-study-of-reqorsa-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302106790.html
https://www.prnewswire.com/news-releases/genprex-collaborators-publish-positive-preclinical-data-with-nprl2-gene-therapy-utilizing-oncoprex-delivery-system-302105455.html
https://www.prnewswire.com/news-releases/genprex-receives-notice-of-patent-grant-for-korean-patent-claiming-reqorsa-immunogene-therapy-with-pd-1-and-pd-l1-antibodies-to-treat-cancers-302085870.html
https://www.prnewswire.com/news-releases/genprex-announces-1-for-40-reverse-stock-split-effective-february-2-2024-302049361.html
https://www.prnewswire.com/news-releases/genprex-provides-business-update-and-outlook-for-2024-302026775.html
https://www.prnewswire.com/news-releases/genprex-to-present-data-on-the-use-of-reqorsa-for-the-treatment-of-lung-cancers-at-2023-2023-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-301947014.html
https://www.globenewswire.com//news-release/2023/09/21/2747274/0/en/Genprex-Inc-NASDAQ-GNPX-Receives-Orphan-Drug-Designation-for-Immunogene-Therapy-for-Treatment-of-SCLC.html
https://www.prnewswire.com/news-releases/genprex-appoints-suzanne-thornton-jones-as-senior-vice-president-regulatory-affairs-301906397.html
https://www.prnewswire.com/news-releases/genprex-granted-fda-orphan-drug-designation-odd-for-reqorsa-immunogene-therapy-for-the-treatment-of-small-cell-lung-cancer-301897630.html